SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-22-001714
Filing Date
2022-02-11
Accepted
2022-02-11 17:17:18
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 BENEFICIAL OWNERSHIP ownership.html 5  
1 BENEFICIAL OWNERSHIP ownership.xml 5 3446
  Complete submission text file 0001387131-22-001714.txt   4944
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDINGS CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
SULLIVAN GREGORY M (Reporting) CIK: 0001610106 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36019 | Film No.: 22622734